![]() |
Radiosurgery for Gliomas See the
Cyberknife section here |
| Is there a survival benefit? from the references noted, there is some evidence that survival may be prolonged (but the ASTRO position on benefit is negative see here.) - Shrieve (Harvard) noted survival in GBM of 19.9 mos and longer by class (III 29.5 mos, IV 19,2 mos and V 18.2 mos) - Sarkaria (Wisconsin) noted better 2 year survival than with conventional therapy (class I/II 76% increased to 81%, III 35% to 75% for IV 15% went to 34% and even class V/VI survival increased from 6% to 21%) - Kondziolka (Pitt) noted survival of 26 mos (51%/2y) for GBM and 32 mos (67%/2y) for anaplastic astro, higher than with conventional therapy - Nwokedi (Maryland) survival inceased from 13 mos to 25 mos with the addition of a gamma knife boost What dose to use? - Pitt after 55-60Gy EBT use marginal dose of 15.5 - 16Gy (in literature 12-20Gy) - Buatti (UF) 60Gy EBT then 12.5 gy (80% IDL) - Gaunett (Arizona) 59.4Gy EBT then 10Gy - Loeffler (Harvard) 59.4Gy EBT then 12Gy (10-20) min and 15Gy (12-25) max -Mehta (Wisconsin) 54Gy EBT then 10-20Gy min (15-35Gy max) -Cho (Minnesota) for retreats after EBT used 17Gy (50% IDL) -Nwokedi (U Maryland) EBT (59.7Gy) then 17Gy (50% IDL) ( diameter pre-EBT of < 4cm, avg volume treated 18.5cc) -RTOG (90-05 and used in 93-05) 60Gy EBT plus 24Gy (2cm) 18Gy (2.1 -3cm) and 15Gy (3.1-4cm) at margin (50-90% IDL) |
